Ocular and neurosyphilis: epidemiology and approach to management.
Journal
Current opinion in infectious diseases
ISSN: 1473-6527
Titre abrégé: Curr Opin Infect Dis
Pays: United States
ID NLM: 8809878
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
4
12
2019
medline:
24
3
2021
entrez:
3
12
2019
Statut:
ppublish
Résumé
In the context of a resurgence of syphilis worldwide, it can be anticipated that a rise in cases of ocular, otic, and neurosyphilis will also be seen. This article reviews the current epidemiology, manifestations, and approach to management and treatment. Although studies continue investigating alternate approaches and new diagnostic tests for ocular and neurosyphilis, few data exist to change current diagnostic algorithms and approaches to diagnosis, management, or follow up. The diagnosis of neurologic and eye/ear involvement with syphilis may be delayed because of a lack of specificity of findings, low suspicion for syphilis, fluctuation in symptoms, and/or similarities in presentation to other diseases. A high index of suspicion for syphilis and re-education about the protean manifestations of syphilis by all clinicians is required provide timely diagnosis and management of ocular, otic, and neurosyphilis.
Identifiants
pubmed: 31789673
doi: 10.1097/QCO.0000000000000617
pii: 00001432-202002000-00010
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
66-72Références
Kiss S, Damico FM, Young LH. Ocular manifestations and treatment of syphilis. Semin Ophthalmol 2005; 20:161–167.
Choudhri Y, Miller J, Sandhu J, et al. Infectious and congenital syphilis in Canada. Can Commun Dis Rep 2018; 44:43–48.
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2017. https://www.cdc.gov/std/stats17/syphilis.htm. (Accessed 8 August 2019).
Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2017. https://data.kirby.unsw.edu.au/STIs. (Accessed 8 August 2019).
Kitayama K, Segura ER, Lake JE, et al. Syphilis in the Americas: a protocol for a systematic review of syphilis prevalence and incidence in four high-risk groups, 1980-2016. Syst Rev 2017; 6:195.
Marra CM. Neurosyphilis. Continuum (Minneap Minn) 2015; 21:1714–1728.
Tuddenham S, Ghanem KG. Ocular syphilis: Opportunities to address important unanswered questions. Sex Transm Infect 2016; 92:563–565.
Merritt H, Adams R, Solomon H. Neurosyphilis. New York: Oxford University Press; 1946.
Clark EG, Danbolt N. The Oslo study of the natural history of untreated syphilis; an epidemiologic investigation based on a restudy of the Boeck-Bruusgaard material; a review and appraisal. J Chronic Dis 1955; 2:311–344.
Taylor MM, Aynalem G, Olea LM, et al. A consequence of the syphilis epidemic among men who have sex with men (MSM): neurosyphilis in Los Angeles, 2001–2004. Sex Transm Dis 2008; 35:430–434.
Daey Ouwens IM, Koedijk FD, Fiolet AT, et al. Neurosyphilis in the mixed urban-rural community of the Netherlands. Acta Neuropsychiatr 2014; 26:186–192.
Lester RT, Morshed M, Gilbert M, et al. Syphilis and neurosyphilis increase to historic levels in BC. BC Med 2013; 55:204–205.
Tang W, Huang S, Chen L, et al. Late neurosyphilis and tertiary syphilis in Guangdong Province, China: results from a crosssectional study. Sci Rep 2017; 7:45339.
Landry T, Smyczek P, Cooper R, et al. Retrospective review of tertiary and neurosyphilis cases in Alberta, 1973 to 2017. BMJ Open 2019; 9:e025995.
Klauder JV. An appreciation of Wassermann in relation to ocular syphilis. AMA Arch Derm 1956; 73:464–468.
Oliver SE, Aubin M, Atwell L, et al. Ocular syphilis - eight jurisdictions, United States, 2014-2015. MMWR Morb Mortal Wkly Rep 2016; 65:1185–1188.
Oliver S, Sahi SK, Tantalo LC, et al. Molecular typing of treponema pallidum in ocular syphilis. Sex Transm Dis 2016; 43:524–527.
Theeuwen H, Whipple M, Litvack JR. Otosyphilis: resurgence of an old disease. Laryngoscope 2019; 129:1680–1684.
Raiziss GW, Severac M. Rapidity with which Spirochaeta pallida invade the bloodstream. Arch Derm Syphilol 1937; 35:1101–1109.
Lukehart SA, Hook EW 3rd, Baker-Zander SA, et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109:855–862.
Hay PE, Clarke JR, Taylor-Robinson D, Goldmeier D. Detection of treponemal DNA in CSF of patients with syphilis and HIV infection using the polymerase chain reaction. Genitourin Med 1990; 66:428–432.
Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The syphilis and HIV study group. N Engl J Med 1997; 337:307–314.
Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189:369–376.
Keidel A, Moore JE. Studies in asymptomatic neurosyphilis I: a tentative classification of early asymptomatic neurosyphilis. Arch Neurol Psychiatry 1921; 6:286–291.
O’Leary PA, Cole HN, Moore JE, et al. Cooperative clinical studies in the treatment of syphilis: asymptomatic neurosyphilis. Arch Derm Syphilol 1937; 35:387–401.
Moore JE. Asymptomatic neurosyphilis V: a comparison of early and late asymptomatic neurosyphilis. Arch Derm Syphilol 1928; 18:99–108.
Moore JE. The modern treatment of syphilis. 2nd ed.Baltimore: Charles C. Thomas; 1943.
Hooshman H, Escobar MR, Kopf SW. Neurosyphilis A Study of 241 patients. JAMA 1972; 219:726–729.
Hotson JR. Modern neurosyphilis: a partially treated chronic meningitis. West J Med 1981; 135:191–200.
Simon RP. Neurosyphilis. Arch Neurol 1985; 42:606–613.
Merritt HH. The early clinical and laboratory manifestations of syphilis of the central nervous system. N Engl J Med 1940; 223:446–450.
Rockwell DH, Yobs AR, Moore MB Jr. The Tuskegee study of untreated syphilis: the 30th year of observation. Arch Intern Med 1964; 114:792–798.
Asdaghi N, Muayqil T, Scozzafava J, et al. The re-emergence in Canada of meningovascular syphilis: 2 patients with headache and stroke. CMAJ 2007; 176:1699–1700.
Romberg EH. Pupillary disturbances in tabes. Zeitschrift Fur Die Gesamte Neurologie Und Psychiatrie 1939; 165:369–372.
Merritt HH, Moore M. The Argyll Robertson pupil: an anatomic-physiologic explanation of the phenomenon, with a survey of its occurrence in neurosyphilis. Arch Neurol Psychiatry 1933; 30:357–373.
Shen S, Yang R, Wang L, et al. Multiple intracranial and spinal cord syphilitic gummas in a human immunodeficiency virus-negative man with untreated syphilis: A case report. Medicine 2019; 98:e16887.
Ormerod LD, Puklin JE, Sobel JD. Syphilitic posterior uveitis: correlative findings and significance. Clin Infect Dis 2001; 32:1661–1673.
Spoor TC, Wynn P, Hartel WC, Bryan CS. Ocular syphilis. Acute and chronic. J Clin Neuroophthalmol 1983; 3:197–203.
Furtado JM, Arantes TE, Nascimento H, et al. Clinical manifestations and ophthalmic outcomes of ocular syphilis at a time of re-emergence of the systemic infection. Sci Rep 2018; 8:12071.
Oliver GF, Stathis RM, Furtado JM, et al. Current ophthalmology practice patterns for syphilitic uveitis. Br J Ophthalmol 2019; 0:1–5.
Moradi A, Salek S, Daniel E, et al. Clinical features and incidence rates of ocular complications in patients with ocular syphilis. Am J Ophthalmol 2015; 159: 334-43.e1.
Morshed M, Singh AE. Recent trends in the serologic diagnosis of syphilis (Review). Clin Vaccine Immunol 2014. [Epub ahead of print]
CDC. Clinical advisory: ocular syphilis in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. https://www.cdc.gov/std/syphilis/clinicaladvisoryos2015.htm. [Accessed 16 October 2019].
Centers for Disease Control and Prevention. 2015 STD Treatment Guidelines: Syphilis. https://www.cdc.gov/std/tg2015/syphilis.htm. [Accessed 15 October 2019].
Kingston M, French P, Higgins S, et al. Members of the Syphilis guidelines revision group. UK national guidelines on the management of syphilis 2015. Int J STD AIDS 2016; 27:421–446.
Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections, Syphilis Chapter. https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/sexually-transmitted-infections/canadian-guidelines-sexually-transmitted-infections-27.html. [Accessed 15 October 2019].
Seña AC, Zhang XH, Li T, et al. A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: Rethinking the significance of serological nonresponsiveness and the serofast state after therapy. BMC Infect Dis 2015; 15:479.
Moore JE, Hopkins HH. Asymptomatic neurosyphilis VI. The prognosis of early and late asymptomatic neurosyphilis. JAMA 1930; 95:1637–1641.
Davis LE, Schmitt JW. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 1989; 25:50–55.
Marra CM, Maxwell CL, Collier AC, et al. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007; 7:37.
Harding AS, Ghanem KG. The performance of cerebrospinal fluid treponemal-specific antibody tests in neurosyphilis: a systematic review. Sex Transm Dis 2012; 39:291–297.
Marks M, Lawrence D, Kositz C, Mabey D. Diagnostic performance of PCR assays for the diagnosis of neurosyphilis: a systematic review. Sex Transm Infect 2018; 94:585–588.
Clement ME, Okeke NL, Hicks CB. Treatment of syphilis: a systematic review. JAMA 2014; 312:1905–1917.
Mohr JA, Griffiths W, Jackson R, et al. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976; 236:2208–2209.
Buitrago-Garcia D, Martí-Carvajal AJ, Jimenez A, et al. Antibiotic therapy for adults with neurosyphilis. Cochrane Database Syst Rev 2019; 5:CD011399.
Fathilah J, Choo MM. The Jarisch-Herxheimer reaction in ocular syphilis. Med J Malaysia 2003; 58:437–439.
Pichi F, Ciardella AP, Cunningham ET Jr, et al. Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy. Retina 2014; 34:373–384.
Conde-Sendin MA, Amela-Peris R, Aladro-Benito Y, et al. Current clinical spectrum of neurosyphilis in immunocompetent patients. Eur Neurol 2004; 52:29–35.
Bollemeijer JG, Wieringa WG, Missotten TOAR, et al. Clinical manifestations and outcome of syphilitic uveitis. Invest Ophthalmol Vis Sci 2016; 57:404–411.
Tsuboi M, Nishijima T, Yashiro S, et al. Prognosis of ocular syphilis in patients infected with HIV in the antiretroviral therapy era. Sex Transm Infect 2016; 92:605–610.
Hoogewoud F, Frumholtz L, Loubet P, et al. Prognostic factors in syphilitic uveitis. Ophthalmology 2017; 124:1808–1816.
Marra CM, Maxwell CL, Sahi SK, et al. Previous syphilis alters the course of subsequent episodes of syphilis. Clin Infect Dis 2019.
Dattner B, Thomas EW, de Mello L. Criteria for the management of neurosyphilis. Am J Med 1951; 10:463–467.
Jordan KG. Modern neruosyphilis – a critical analysis. West J Med 1988; 149:47–57.
Marra CM, Longstreth WT Jr, Maxwell CL, Lukehart SA. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection. Sex Transm Dis 1996; 23:184–189.
Marra CM, Maxwell CL, Tantalo LC, et al. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008; 47:893–899.
Ghanem KG, Workowski KA. Management of adult syphilis. Clin Infect Dis 2011; 53: (Suppl 3): S110–S128.
Libois A, De Wit S, Poll B, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007; 34:141–144.
Sun JJ, Wang ZY, Shen JY, et al. Serum TRSUT Titer >/.1: 16 is a predictor for neurosyphilis among HIV-infected patients with concurrent syphilis and no neurological symptoms. Medicine (Baltimore) 2015; 94:e2023.
Ghanem KG, Moore RD, Rompalo AM, et al. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008; 22:1145–1151.
Dumaresq J, Langevin S, Gagnon S, et al. Clinical prediction and diagnosis of neurosyphilis in HIV-infected patients with early Syphilis. J Clin Microbiol 2013; 51:4060–4066.
Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83:97–101.
Gonzalez-Lopez JJ, Guerrero MLF, Lujan R, et al. Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis 2009; 49:1505–1511.
Goeman J, Kivuvu M, Nzila N, et al. Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med 1995; 71:275–279.
Manavi K, McMillan A. The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients. Int J STD AIDS 2007; 18:814–818.
Jinno S, Anker B, Kaur P, et al. Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use. BMC Infect Dis 2013; 13:605.
Andrade R, Rodriguez-Barradas MC, Yasukawa K, et al. Single dose versus 3 doses of intramuscular benzathine penicillin for early syphilis in HIV: a randomized clinical trial. Clin Infect Dis 2017; 64:759–764.
Ghanem KG, Moore RD, Rompalo AM, et al. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis 2008; 47:258–265.
Salamano R, Ballesté R, Perna A, et al. Cerebrospinal fluid examination may be useful in diagnosing neurosyphilis in asymptomatic HIV+ patients with syphilis. Arq Neuropsiquiatr 2016; 74:128–132.
Wang C, Wu K, Yu Q, et al. CXCL13, CXCL10 and CXCL8 as potential biomarkers for the diagnosis of Neurosyphilis patients. Sci Rep 2016; 6:33569.
Lu RXH, Lu C, Hu S, et al. Value of CXCL13 in diagnosing asymptomatic Neurosyphilis in HIV-infected patients. Int J STD AIDS 2015; 27:141–146.